Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-18-028713
Filing Date
2018-05-08
Accepted
2018-05-08 20:10:50
Documents
1
Period of Report
2018-05-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4829
  Complete submission text file 0001209191-18-028713.txt   6362
Mailing Address 12544 HIGH BLUFF DRIVE SUITE 200 SAN DIEGO CA 92130
Business Address 12544 HIGH BLUFF DRIVE SUITE 200 SAN DIEGO CA 92130 8585521100
QUIDEL CORP /DE/ (Issuer) CIK: 0000353569 (see all company filings)

EIN.: 942573850 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address STANFORD UNIVERSITY SCHOOL OF MEDICINE 300 PASTAUR DR ROOM HH333 STANFORD CA 94305-5317
Business Address
POLAN MARY LAKE PH D (Reporting) CIK: 0001187716 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-10961 | Film No.: 18816372